Quaker Chemical Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Quaker Chemical wird ein jährliches Gewinn- und Umsatzwachstum von 63.8% bzw. 3.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 91.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.3% betragen.
Wichtige Informationen
63.8%
Wachstumsrate der Gewinne
91.89%
EPS-Wachstumsrate
| Chemicals Gewinnwachstum | 17.4% |
| Wachstumsrate der Einnahmen | 3.9% |
| Zukünftige Eigenkapitalrendite | 12.35% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 06 May 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Narrativ-Update • May 01
KWR: Share Gains And M&A Execution Will Support Future P/E Premium
Analysts have modestly reduced the fair value estimate for Quaker Chemical to $180 from $184. This reflects updated views on slightly higher long term revenue growth, a somewhat stronger profit margin profile, a lower assumed future P/E multiple, and a marginally lower discount rate following a mix of recent target cuts and upgrades on the stock.Narrativ-Update • Apr 17
KWR: Market Share Gains And M&A Activity Will Support Future P/E Premium
Analysts have trimmed their average price target for Quaker Chemical to about $184 from roughly $203 as they factor in softer revenue growth assumptions, a lower future P/E, and updated views from recent research that cites more moderate sales and EBITDA expectations despite ongoing share gains in subdued end markets. Analyst Commentary Recent research on Quaker Houghton has been mixed, but several bullish analysts still see room for upside based on execution, valuation, and the company’s ability to grow share even in softer end markets.
Narrativ-Update • Apr 01
KWR: M&A Execution And Share Gains Will Support Future Upside
Narrative Update: Quaker Chemical Analyst Price Target Shift Analysts now center their price target for Quaker Chemical around $183, reflecting a blend of Seaport's downgrade, Deutsche Bank's lift to $170, and RBC Capital's reset to $184 after Q4 results and softer 2026 guidance, while still acknowledging ongoing share gains in flat to slightly weaker end markets. Analyst Commentary Recent research on Quaker Chemical highlights a split view on how the story stacks up after Q4 results and updated guidance, with price targets clustering in the mid to high $100s.Narrativ-Update • Mar 17
KWR: Market Share Gains And M&A Focus Will Support Premium P/E Multiple
Quaker Chemical's updated analyst price target has moved from $190 to $203, with analysts pointing to revised assumptions on revenue growth, profit margins, and a higher future P/E multiple, informed by recent target changes at firms covering Quaker Houghton. Analyst Commentary Recent research on Quaker Chemical, which operates as Quaker Houghton, reflects a mix of higher and lower price targets and at least one ratings downgrade, giving you a range of views on how the company is executing and how the stock is valued today.Narrativ-Update • Mar 03
KWR: Higher Earnings Multiple And M&A Activity Will Support Future Upside
Analysts have lifted their blended price target for Quaker Houghton to about $183, up from roughly $172, as they weigh softer guidance and margin assumptions against continued share gains and updated P/E expectations reflected in recent research moves. Analyst Commentary Recent research on Quaker Houghton reflects a mix of optimism and caution, with price targets being fine tuned around updated growth, margin and P/E expectations following the latest earnings and guidance.Narrativ-Update • Feb 17
KWR: Updated Assumptions And Mixed Ratings Will Shape Balanced Future Expectations
Analysts have raised their price target on Quaker Chemical to $172.25 from $166. This change reflects updated views on fair value, a slightly lower discount rate, modest adjustments to long-term revenue and margin assumptions, and a somewhat higher assumed future P/E multiple.Narrativ-Update • Feb 03
KWR: Higher Margin Assumptions Will Reframe Earnings Risk Ahead Of Results
Analysts have raised their fair value estimate for Quaker Chemical to $190 from $165, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E levels in recent research. Analyst Commentary Recent Street research on Quaker Chemical points to a mixed but increasingly engaged analyst view, with some firms revisiting their assumptions around earnings and valuation ahead of upcoming results.Narrativ-Update • Jan 20
KWR: Completed Buybacks And Steady Assumptions Will Shape Balanced Future Prospects
Analysts have reaffirmed their view on Quaker Chemical, keeping the fair value estimate steady at $166.00 as small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions did not materially shift their overall price target framework. What's in the News From July 1, 2025 to September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17% of its shares.Analyseartikel • Jan 11
These 4 Measures Indicate That Quaker Chemical (NYSE:KWR) Is Using Debt Reasonably Well
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Narrativ-Update • Jan 06
KWR: Share Repurchases And Stable Assumptions Will Support Future Upside Potential
Analysts kept their price target for Quaker Chemical steady at $166, reflecting only small model tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a change in their overall view of the shares. What's in the News From July 1, 2025 to September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17% of its shares.Narrativ-Update • Dec 20
KWR: Ongoing Share Repurchases Will Likely Support Strong Future Share Performance
Narrative Update Analysts have raised their price target on Quaker Chemical by $0.00 to account for slightly lower discount rate assumptions and modest adjustments to long-term growth and profitability forecasts. What's in the News Completed share repurchase of 638,901 shares, about 3.59% of outstanding shares, for a total of $85.75 million under the buyback program announced on February 28, 2024 (company filing) Between July 1, 2025 and September 30, 2025, repurchased 29,791 shares, representing 0.17% of shares, for $3.81 million as the final tranche of the current authorization (company filing) Ongoing capital return via buybacks signals management confidence in long term cash generation and balance sheet strength (company filing) Valuation Changes Fair Value: unchanged at $166.00 per share, reflecting no net impact from the updated assumptions.Analyseartikel • Dec 19
There's Been No Shortage Of Growth Recently For Quaker Chemical's (NYSE:KWR) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Narrativ-Update • Dec 06
KWR: Ongoing Share Repurchases Will Likely Support Strong Future Share Performance
Narrative Update on Quaker Chemical Analysts have maintained their price target for Quaker Chemical at approximately 166 dollars, as modest adjustments to the discount rate and long term growth assumptions were not deemed sufficient to warrant a change in fair value. What's in the News The company completed its share repurchase program announced on February 28, 2024, buying back a total of 638,901 shares, or about 3.59% of shares outstanding, for approximately 85.75 million dollars (company filing).Narrativ-Update • Nov 22
KWR: Share Repurchases Are Expected To Drive Positive Market Reactions
Narrative Update on Quaker Chemical Analysts have raised their price target for Quaker Chemical from $162 to $166, reflecting a modest increase based on updated assessments of company valuation metrics and market outlook. What's in the News Between July 1, 2025 and September 30, 2025, Quaker Chemical repurchased 29,791 shares for $3.81 million, representing 0.17 percent of its outstanding shares (Key Developments).Narrativ-Update • Nov 03
KWR: Expanding Share Buybacks Will Drive Stronger Profit Margins Ahead
Analysts have raised their price target for Quaker Chemical from $155.40 to $162.00. They cite improved profit margin forecasts and higher projected revenue growth as key factors in the revised valuation.Seeking Alpha • Oct 08
Quaker Chemical: The Worst Should Be Behind Us Now
Summary Quaker Chemical remains a leader in industrial process fluids, with strong R&D investment and a robust underlying cash flow engine. Despite reported net losses from impairment and restructuring, KWR's underlying free cash flow reached $53M in H1, with pro forma FCF at $90M. Management expects stable revenue and earnings for 2025 (compared to the 2024 performance), with capex guidance lowered and leverage expected to decline after the Dipsol acquisition. KWR is rated a 'speculative buy' due to anticipated cost savings, improving free cash flow, and a projected 6% FCF yield, despite not being cheap. Read the full article on Seeking AlphaAnalyseartikel • Oct 02
Quaker Chemical's (NYSE:KWR) Upcoming Dividend Will Be Larger Than Last Year's
Quaker Chemical Corporation ( NYSE:KWR ) will increase its dividend from last year's comparable payment on the 31st of...Analyseartikel • Sep 24
Is There An Opportunity With Quaker Chemical Corporation's (NYSE:KWR) 48% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Quaker Chemical fair value estimate is US$258 Quaker...Analyseartikel • Aug 30
Quaker Chemical Corporation's (NYSE:KWR) 26% Price Boost Is Out Of Tune With Revenues
Despite an already strong run, Quaker Chemical Corporation ( NYSE:KWR ) shares have been powering on, with a gain of...Narrativ-Update • Aug 28
Sustainable Chemistries And Asia Expansion Will Empower Manufacturing Automation
The upward revision in Quaker Chemical’s consensus price target reflects a minor increase in forecasted future P/E ratio, while valuation inputs like the discount rate remain stable, resulting in a fair value target rising to $155.40. What's in the News Reported an $88.8 million goodwill impairment charge related to the EMEA segment, resulting in a quarterly net loss.Analyseartikel • May 28
Is Now An Opportune Moment To Examine Quaker Chemical Corporation (NYSE:KWR)?
Quaker Chemical Corporation ( NYSE:KWR ), might not be a large cap stock, but it saw a decent share price growth of 15...Analyseartikel • Apr 25
Quaker Chemical Corporation (NYSE:KWR) Shares Could Be 49% Below Their Intrinsic Value Estimate
Key Insights Quaker Chemical's estimated fair value is US$206 based on 2 Stage Free Cash Flow to Equity Quaker...Analyseartikel • Apr 08
Risks Still Elevated At These Prices As Quaker Chemical Corporation (NYSE:KWR) Shares Dive 27%
Quaker Chemical Corporation ( NYSE:KWR ) shareholders that were waiting for something to happen have been dealt a blow...Seeking Alpha • Mar 26
Quaker Chemical: Starting To Look More Attractive
Summary Quaker Chemical Corporation's valuation has become more compelling, but I'm cautious due to economic concerns and recent CEO turnover. Despite a 6% sales drop in early 2024, earnings held up, and net debt decreased to $519 million. The $153 million acquisition of Dipsol Chemicals is expected to slightly boost earnings and maintain a manageable debt level. While the KWR earnings multiple has improved, economic uncertainties and tariff impacts make me hesitant to buy now. Read the full article on Seeking AlphaAnalyseartikel • Feb 03
We Like These Underlying Return On Capital Trends At Quaker Chemical (NYSE:KWR)
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...Analyseartikel • Jan 19
Does Quaker Chemical (NYSE:KWR) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • Jan 03
Quaker Chemical Corporation's (NYSE:KWR) Earnings Haven't Escaped The Attention Of Investors
It's not a stretch to say that Quaker Chemical Corporation's ( NYSE:KWR ) price-to-sales (or "P/S") ratio of 1.3x seems...Analyseartikel • Dec 15
Is There An Opportunity With Quaker Chemical Corporation's (NYSE:KWR) 46% Undervaluation?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Quaker Chemical fair value estimate is US$282 Current share...Analyseartikel • Nov 02
Quaker Chemical (NYSE:KWR) Shareholders Will Want The ROCE Trajectory To Continue
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Analyseartikel • Oct 17
Why Quaker Chemical Corporation (NYSE:KWR) Could Be Worth Watching
Quaker Chemical Corporation ( NYSE:KWR ), might not be a large cap stock, but it saw significant share price movement...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2028 | 2,125 | 195 | 128 | 227 | 2 |
| 12/31/2027 | 2,087 | 154 | 158 | 231 | 6 |
| 12/31/2026 | 2,003 | 97 | 107 | 182 | 6 |
| 3/31/2026 | 1,926 | 4 | 89 | 143 | N/A |
| 12/31/2025 | 1,889 | -2 | 81 | 136 | N/A |
| 9/30/2025 | 1,864 | -9 | 97 | 153 | N/A |
| 6/30/2025 | 1,833 | -7 | 119 | 170 | N/A |
| 3/31/2025 | 1,813 | 94 | 125 | 174 | N/A |
| 12/31/2024 | 1,840 | 116 | 163 | 205 | N/A |
| 9/30/2024 | 1,863 | 122 | 189 | 221 | N/A |
| 6/30/2024 | 1,891 | 123 | 204 | 237 | N/A |
| 3/31/2024 | 1,923 | 118 | 231 | 268 | N/A |
| 12/31/2023 | 1,953 | 112 | 240 | 279 | N/A |
| 9/30/2023 | 1,971 | 16 | 233 | 268 | N/A |
| 6/30/2023 | 1,973 | 9 | 136 | 166 | N/A |
| 3/31/2023 | 1,970 | -6 | 60 | 86 | N/A |
| 12/31/2022 | 1,944 | -16 | 13 | 42 | N/A |
| 9/30/2022 | 1,906 | 78 | -9 | 20 | N/A |
| 6/30/2022 | 1,863 | 83 | 20 | 50 | N/A |
| 3/31/2022 | 1,806 | 102 | 29 | 55 | N/A |
| 12/31/2021 | 1,761 | 121 | 27 | 49 | N/A |
| 9/30/2021 | 1,700 | 151 | 50 | 69 | N/A |
| 6/30/2021 | 1,618 | 147 | 107 | 124 | N/A |
| 3/31/2021 | 1,469 | 106 | 129 | 146 | N/A |
| 12/31/2020 | 1,418 | 40 | 160 | 178 | N/A |
| 9/30/2020 | 1,423 | 6 | 141 | 159 | N/A |
| 6/30/2020 | 1,381 | -34 | 87 | 105 | N/A |
| 3/31/2020 | 1,301 | -11 | 85 | 103 | N/A |
| 12/31/2019 | 1,134 | 32 | N/A | 82 | N/A |
| 9/30/2019 | 954 | 24 | N/A | 63 | N/A |
| 6/30/2019 | 851 | 57 | N/A | 81 | N/A |
| 3/31/2019 | 867 | 60 | N/A | 76 | N/A |
| 12/31/2018 | 868 | 59 | N/A | 79 | N/A |
| 9/30/2018 | 867 | 42 | N/A | 75 | N/A |
| 6/30/2018 | 858 | 33 | N/A | 64 | N/A |
| 3/31/2018 | 837 | 26 | N/A | 59 | N/A |
| 12/31/2017 | 820 | 20 | N/A | 65 | N/A |
| 9/30/2017 | 800 | 47 | N/A | 62 | N/A |
| 6/30/2017 | 778 | 52 | N/A | 59 | N/A |
| 3/31/2017 | 763 | 55 | N/A | 71 | N/A |
| 12/31/2016 | 747 | 61 | N/A | 74 | N/A |
| 9/30/2016 | 739 | 55 | N/A | 76 | N/A |
| 6/30/2016 | 737 | 53 | N/A | 82 | N/A |
| 3/31/2016 | 734 | 53 | N/A | 76 | N/A |
| 12/31/2015 | 738 | 51 | N/A | 73 | N/A |
| 9/30/2015 | 748 | 52 | N/A | 67 | N/A |
| 6/30/2015 | 758 | 53 | N/A | 74 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: KWRDas prognostizierte Gewinnwachstum (63.8% pro Jahr) liegt über der Sparquote (3.5%).
Ertrag vs. Markt: KWRDie Erträge des Unternehmens (63.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (16.8% pro Jahr).
Hohe Wachstumserträge: KWREs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: KWRDie Einnahmen des Unternehmens (3.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.7% pro Jahr).
Hohe Wachstumseinnahmen: KWRDie Einnahmen des Unternehmens (3.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: KWRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.3%).
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/18 00:48 |
| Aktienkurs zum Tagesende | 2026/05/18 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Quaker Chemical Corporation wird von 13 Analysten beobachtet. 6 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Michael Gaugler | Brean Capital Historical (Janney Montgomery) |
| Liam Burke | B. Riley Securities, Inc. |
| Jonathan Tanwanteng | CJS Securities, Inc. |